Disclosures for "Is the Mental Health Burden of Epilepsy Under-Recognized in Patients Reporting Focal Onset Seizures (FOS)? A Patient-Reported Outcomes Study"
-
Dr. Wagner has received personal compensation for serving as an employee of Xenon Pharmaceuticals, Inc.. Dr. Wagner has stock in Biogen. Dr. Wagner has stock in Xenon Pharmaceuticals, Inc..
-
Dr. Oak has received personal compensation for serving as an employee of Trinity Life Sciences. An immediate family member of Dr. Oak has received personal compensation for serving as an employee of Intellia Therapeutics. An immediate family member of Dr. Oak has stock in Intellia Therapeutics.
-
Miss Smith has received personal compensation for serving as an employee of Trinity Life Sciences.
-
Dr. Athavale has received personal compensation for serving as an employee of Trinity Life Sciences. Dr. Athavale has stock in Trinity Life Sciences.
-
Dr. Skaar has received personal compensation for serving as an employee of Trinity Life Sciences. Dr. Skaar has received personal compensation for serving as an employee of Novo Nordisk. Dr. Skaar has stock in Trinity Life Sciences. Dr. Skaar has stock in Novo Nordisk.
-
Dr. Ong has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Ong has stock in Xenon Pharmaceuticals.
-
Author has nothing to disclose